July 14, 2024: Ozempic Lawsuit Intensifies with New Studies Linking Drug to Vision Loss The Ozempic blindness and vision loss lawsuit is full steam ahead following the July 2024 study indicating huge increases in the risk of NAION for users of semaglutide
The post says some plans cover semaglutide only for type 2 diabetes and not for obesity, which creates a gap for weight-loss-only requests
If you developed gastroparesis in 2024 but did not learn until 2025 that it could be connected to your GLP-1 medication, the discovery rule may extend your filing deadline
That is how you build a way of eating that fits your real life
Some report a tight sensation in the chin area, but pain is minimal
In some developed countries, statistics by the National Institutes of Health seem to suggest that 5 in 10 Semaglutide drugs may be counterfeit or inferior, although the global average stands at about 10.5%